![John LaRocca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John LaRocca
Directeur/Membre du Conseil chez
BETTERLIFE PHARMA INC.
Fortune : - $ au 31/07/2026
Profil
John W.
LaRocca is currently Director at BetterLife Pharma, Inc. since 2026.
Formerly, Mr. LaRocca was Chief Legal Officer & General Counsel at Y-mAbs Therapeutics, Inc. from 2024 to 2025.
Served as Secretary & General Counsel at Aerie Pharmaceuticals, Inc. from 2018 to 2022.
Held the position of Chief Compliance Officer, EVP & General Counsel at Eagle Pharmaceuticals, Inc. from 2015 to 2018.
Worked as Deputy General Counsel at Allergan UC from 2013 to 2014.
Was Chief Legal Officer-Americas Region at Actavis, Inc. from 2005 to 2012.
Held the role of Divisional Counsel-US Generics at Alpharma Specialty Pharma LLC from 2000 to 2005.
Also held the same title at Purepac Pharmaceutical Co. from 2000 to 2005.
Education includes graduate degree from Columbia Law School and undergraduate degree from Columbia College (New York).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de John LaRocca
| Sociétés | Poste | Début |
|---|---|---|
| BETTERLIFE PHARMA INC. | Directeur/Membre du Conseil | 09/07/2026 |
Anciens postes connus de John LaRocca
| Sociétés | Poste | Fin |
|---|---|---|
| YMAS THER | Conseiller Juridique Général | 16/09/2025 |
| AERIE PHARMACEUTICALS, INC. | Conseiller Juridique Général | 21/11/2022 |
| EAGLE PHARMACEUTICALS, INC. | Compliance Officer | 01/01/2018 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/12/2014 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Corporate Officer/Principal | 01/12/2012 |
Formation de John LaRocca
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Alpharma Specialty Pharma LLC
 Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Distributes multi-source injectable pharmaceutical drugs | Distribution Services |
Purepac Pharmaceutical Co.
 Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Manufactures generic equivalent drugs | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
BetterLife Pharma, Inc.
 BetterLife Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of therapeutic pharmaceutical products | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia College (New York)
 Columbia College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
